Nebenwirkungen · Degarelix Accord
Degarelix Accord 80 mg powder and solvent for solution for injection Degarelix Accord 120 mg powder and solvent for solution for injection · Abschnitt 4.8 · PDF-Seite 5–6
HOS-151017 · Präparat HOS-100434
5 MedDRA Very Common Uncommon Rare System Organ common Class (SOC) Metabolism and Weight Hyperglycemia/Diabetes mellitus, nutrition increase* cholesterol increased, weight disorders decreased, appetite decreased, changes in blood calcium Psychiatric Insomnia Depression, libido decreased* disorders Nervous system Dizziness, Mental impairment, hypoaesthesia disorders headache Eye disorders Vision blurred Cardiac Cardiac arrhythmia (incl. atrial Myocardial disorders fibrillation), palpitations, QT infarction, cardiac prolongation*(see sections 4.4 and failure 4.5) Vascular Hot flush* Hypertension, vasovagal reaction disorders (incl. hypotension) Respiratory, Dyspnoea thoracic and mediastinal disorders Gastrointestinal Diarrhoea, Constipation, vomiting, abdominal disorders nausea pain, abdominal discomfort, dry mouth Hepatobiliary Liver Bilirubin increased, alkaline disorders transaminases phosphatase increased increased Skin and Hyperhidrosis Urticaria, skin nodule, alopecia, subcutaneous (incl. night pruritus, erythema tissue disorders sweats)*, rash Musculoskeletal Musculoskeletal Osteoporosis/osteopenia, Rhabdomyolysis , connective pain and arthralgia muscular weakness, tissue and bone discomfort muscle spasms, joint disorders swelling/stiffness Renal and Pollakiuria, micturition urgency, urinary disorders dysuria, nocturia, renal impairment, incontinence Reproductive Gynaecomastia*, Testicular pain, breast pain, pelvic system and testicular pain, genital irritation, ejaculation breast disorders atrophy*, failure erectile dysfunction* General Injection Chills, pyrexia, Malaise, peripheral oedema disorders and site fatigue*, administration adverse Influenza- like site conditions reactions illness * Known physiological consequence of testosterone suppression
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-05T16:20:00Z · SHA-256 8d97d2cffef5c790f42b9d13857a0d8bd192f47ade9e728fdd1dd96085b54fbd · Passage b45316a765fe5fe16cc73a293b4c44bec836d77dd3fa83a9ae41e49cd9ccc39d · Zeichen 2366–5602 im Abschnitt